Leoš Rejmont
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leoš Rejmont has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Kateřina Tyx
Department of Ophthalmology, Institute of Aviation Medicine Prague, 160 00 Prague, Czech Republic
1 shared publication - Kristýna Lahodová
Department of Ophthalmology, Institute of Aviation Medicine Prague, 160 00 Prague, Czech Republic
1 shared publication - Ladislav Viktor Nováček
Department of Ophthalmology, School of Medicine Hradec Králové, Charles University Prague, 500 03 Hradec Králové, Czech Republic
1 shared publication - Marie Němcová
Department of Ophthalmology, Institute of Aviation Medicine Prague, 160 00 Prague, Czech Republic
1 shared publication - Pavel Rozsíval
Department of Ophthalmology, School of Medicine Hradec Králové, Charles University Prague, 500 03 Hradec Králové, Czech Republic
1 shared publication - Pavel Studeny
Ophthalmology Department of the Third Medical Faculty, University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 24 July 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (15) , 3268
Comparison of Clinical Outcomes, Visual Quality and Visual Function of Two Presbyopia-Correcting Intraocular Lenses Made from the Same Material, but with Different Design and Optics
This semi-prospective, parallel, comparative investigation evaluated the clinical outcomes and quality of vision (contrast sensitivity, visual function, dysphotopsia, spectacle use, overall satisfaction) after mono- or bilateral implantation of two presbyopia-correcting intraocular lenses (IOL)—the Liberty® 677MY or the AT LISA® tri 839M—in 50 eyes of 25 cataract patients. Clinical outcomes were assessed 3 and 12 months postoperatively. Eighty-nine percent of eyes implanted with the Liberty IOL and 59% of eyes implanted with the AT LISA IOL achieved a refractive outcome ±0.5 diopters of the target (emmetropia). Refractive outcomes were stable with both lenses. The proportions of eyes with 20/20 uncorrected distance visual acuity (UDVA) and 20/20 uncorrected near visual acuity (UNVA) were higher in the Liberty group than in the AT LISA group (UDVA: 56% vs. 41%; UNVA: 83% vs. 66%). Optical quality assessment results were comparable for the two IOLs. Superior photopic contrast sensitivity was found with the Liberty lens. The rate of Nd:YAG capsulotomy at the 12-month follow-up was 16.7% in the Liberty group and 40.6% for the AT LISA IOL. Considering that both lenses are made from the same material, we propose that the noted differences in clinical outcomes may derive from differences in design and optical surface between the two IOLs.
- 24 July 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (15) , 3268
Open AccessComparison of Clinical Outcomes, Visual Quality and Visual Function of Two Presbyopia-Correcting Intraocular Lenses Made from the Same Material, but with Different Design and Optics
This semi-prospective, parallel, comparative investigation evaluated the clinical outcomes and quality of vision (contrast sensitivity, visual function, dysphotopsia, spectacle use, overall satisfaction) after mono- or bilateral implantation of two presbyopia-correcting intraocular lenses (IOL)—the Liberty® 677MY or the AT LISA® tri 839M—in 50 eyes of 25 cataract patients. Clinical outcomes were assessed 3 and 12 months postoperatively. Eighty-nine percent of eyes implanted with the Liberty IOL and 59% of eyes implanted with the AT LISA IOL achieved a refractive outcome ±0.5 diopters of the target (emmetropia). Refractive outcomes were stable with both lenses. The proportions of eyes with 20/20 uncorrected distance visual acuity (UDVA) and 20/20 uncorrected near visual acuity (UNVA) were higher in the Liberty group than in the AT LISA group (UDVA: 56% vs. 41%; UNVA: 83% vs. 66%). Optical quality assessment results were comparable for the two IOLs. Superior photopic contrast sensitivity was found with the Liberty lens. The rate of Nd:YAG capsulotomy at the 12-month follow-up was 16.7% in the Liberty group and 40.6% for the AT LISA IOL. Considering that both lenses are made from the same material, we propose that the noted differences in clinical outcomes may derive from differences in design and optical surface between the two IOLs.